Rapid point-of-care COVID-19 test shows promise in clinical study
September 18, 2020 -- A rapid COVID-19 test that can produce results at the point of care in just 90 minutes without sending samples to a central lab has demonstrated 94% sensitivity and 100% specificity, according to a new study published in the Lancet Microbe.  Discuss
How willing are U.S. adults to accept a COVID-19 vaccine?
September 17, 2020 -- A recent online survey of adults residing in the U.S. found that close to 70% of those surveyed would accept a COVID-19 vaccine if one were widely available. The study findings were published in the journal Vaccine on August 20.  Discuss
Top companies earn 80% of revenue in IVD market
September 11, 2020 -- Most of the revenue in the IVD market is generated by fewer than 20 companies, according to a recent report by IVD market research firm Kalorama Information, a sister company of LabPulse.com, explains Bruce Carlson of Kalorama.  Discuss
Experts draw lessons from FDA's hydroxychloroquine EUA controversy
September 8, 2020 -- Public health and regulatory experts advocated for changes to the U.S. Food and Drug Administration (FDA) emergency use authorization (EUA) process in a viewpoint published online August 31 in the Journal of the American Medical Association. They offer a set of recommendations to improve the process going forward as more COVID-19 vaccines and treatments emerge.  Discuss
Detecting SARS-CoV-2 in blood may be early indicator of severe disease
September 2, 2020 -- A blood test that measures SARS-CoV-2 RNA when patients are admitted to the hospital with COVID-19 symptoms can be a powerful diagnostic tool to predict how severe their disease will be, according to a study published in Clinical Infectious Diseases on August 28. Patients without viral RNA in their blood have a good chance at rapid recovery, concluded researchers from Karolinska Institutet and Danderyd Hospital.  Discuss
Top 5 facts about the IVD market
September 1, 2020 -- The market for IVD tests is vital and rapidly changing. IVD tests serve as a gateway to numerous other healthcare segments, and attract significant research and development spending and venture capital investments. Bruce Carlson of Kalorama Information explains the five facts that make the IVD market unique.  Discuss
FDA authorizes Abbott's COVID-19 real-time antigen test
August 27, 2020 -- The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization for a COVID-19 antigen test developed by Abbott Diagnostics Scarborough from which results can be read directly from the testing card.
Genetic testing cut adverse events in heart patients
August 27, 2020 -- Personalized genetic testing led to a 34% decrease in the number of patients who had serious adverse events following balloon angioplasties, according to results published August 25 in the Journal of the American Medical Association.  Discuss
NIH establishes Centers for Research in Emerging Infectious Diseases
August 27, 2020 -- The National Institute of Allergy and Infectious Diseases, part of the U.S. National Institutes of Health (NIH), has awarded 11 grants for a first-year total value of approximately $17 million to establish the Centers for Research in Emerging Infectious Diseases.  Discuss
Point-of-care testing leads South Korea's response to COVID-19
August 24, 2020 -- What was the secret to South Korea's success in controlling the COVID-19 pandemic? A new study indicates that point-of-care testing played an important role in reducing the spread of SARS-CoV-2 there compared to the U.S., which has experienced 47 times the number of cases and almost 80 times the number of deaths.  Discuss